Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 1,741-1,752 of 6,115
Behavioral study icon
Not recruitingISRCTN58007098

Cognitive behavioural therapy in elderly type 2 diabetes people with minor depression or mild major depression

This study is looking at whether cognitive behavioural therapy can help people with Type 2 diabetes, minor or mild major depression, Mental and Behavioural Disorders, or Depressive episode. Participants receive a study treatment and complete follow-up visits and assessments.

In Germany
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
Germany
Sponsor
Ruhr University of Bochum (Germany)
Condition
Depression
Drug study icon
Not recruitingISRCTN68038781

Effects of ω-3 polyunsaturated fatty acid supplementation in the treatment of adolescents with depressive disorder

This study is testing a medication approach for people with depression, Mental and Behavioural Disorders, or Depressive episode, unspecified. Participants receive a study treatment and complete follow-up visits and assessments.

In China
Why is this study shown?

This study is directly about Depression.

DepressionOther
Countries
China
Sponsor
Shanghai Jiao Tong University
Condition
Depression
Other study type icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
TerminatedNCT05518149

Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)

This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Other study type icon
CompletedNCT07258485

Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in people with Major Depressive Disorder (MDD)

This study is completed in the United States. It is testing Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) for depression.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Depression.

DepressionObservationalFrom 18 Years to 74 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
CompletedNCT06953362

Deciphering Principles of Network Dynamics Underlying Depression Symptom Severity From Multi-day Intracranial Recordings in people with Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Months to 70 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
Drug study icon
CompletedNCT04670081

Psilocybin for depression

This study is completed in Germany. It is testing psilocybin for depression.

Multiple locations, including Berlin
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 25 Years to 65 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Depression
Drug study icon
Active Not RecruitingNCT06308653

Psilocybin for Major Depressive Disorder (MDD)

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Usona Institute
Condition
Depression
Other study type icon
CompletedNCT02489305

Potential Predictors of Relapse in people with Major Depressive Disorder (MDD)

This study is completed in the United States. It is testing potential Predictors of Relapse for depression.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionObservationalFrom 18 Years to 64 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.